FINAL PROGR AM - American Society of Gene & Cell Therapy

More documents

Recommendations

Info

AMERICAN SOCIETY OF GENE THERAPY • Final Program 37 SCIENTIFIC PROGRAM FRIDAY, JUNE 3, 2005 POSTER SESSION II – 4:00 PM - 7:30 PM Hall 2 RNA Virus Vectors: Gene Transfer, Vector Production (Abstracts #474 through #496) AAV Vectors: Vector Biology (Abstracts #497 through #523) Adenovirus Vectors: Applications (Abstracts #524 through #555) Naked DNA Gene Transfer: Optimizing Expression, Animal Models (Abstracts #556 through #575) Lipid Mediated Gene Transfer: Non-Viral Delivery System (Abstracts # 576 through #596) Inborn Errors of Metabolism: Hemophilia (Abstracts #597 through #615) Cardiovascular: Angiogenesis and Vascular Gene Therapy (Abstracts #616 through #639; and Abstract #921) Neurologic: Pain (Abstracts #640 through #646) Neurologic: Spinal Cord Injury and Motor Neuron Disease (Abstracts #647 through #654) Neurologic: Advances in Vectors, Delivery and Imaging (Abstracts #655 through #662) Neurologic: Sensory (Abstracts #663 through #671) Gene Therapy for Connective Tissue (Abstracts #672 through #690) Cancer - Immunotherapy: Cytokine Transgenes and Vaccinations (Abstracts #691 through #709) Cancer - Targeted Gene Therapy: Targeting of Non-Adenoviral Vectors (Abstracts #710 through #732) Gene Regulation: Overcoming Obstacles to Gene Transfer and Expression (Abstracts #733 through #754) EVENING SESSION – 8:30 PM – 10:00 PM Evening Session 340 Immune Responses in Neurologic Gene Therapy - Basic Bench Perspectives Target Audience: Anyone interested in immune responses as well as neural gene therapy in the brain. Room: 261/262 Co-Chairs: Pedro Lowenstein, MD, PhD Hildegund CJ Ertl, MD Speakers: Ronald G. Crystal, MD Paola Leone, PhD James Wilson, MD, PhD Michael Kaplitt, MD, PhD John Iacomini, PhD Roland W. Herzog, PhD Katherine A. High, MD Samuel D. Rabkin, PhD Jean Bennett, MD, PhD David J. Fink, MD Ronald Mandel, PhD
38 8th Annual Meeting • June 1 - 5, 2005 • St. Louis SCIENTIFIC PROGRAM SATURDAY, JUNE 4, 2005 SCIENTIFIC SYMPOSIA – 8:00 AM - 10:00 AM Scientific Symposium 400 Cancer: Clinical Trials Room: Ferrara Theater Chair: Steven M. Albelda, MD Speakers: Daniel H. Sterman, MD - Gene Therapy Clinical Trials for Pleural Malignancies John J. Nemunaitis, MD - Oncolytic Viral Gene Delivery Vehicles Chiara Bonini, MD - Suicide Gene Therapy in Stem Cell Transplantation Kristen Hege, MD - GVAX Cancer Vaccines - Clinical Development Scientific Symposium 401 Cardiovascular: Advances in Cardiovascular Cell and Gene Therapy Room: 230 Complex Co-Chairs: Lawrence C. Chan, MD Douglas Losordo, MD Speakers: Lawrence C. Chan, MD - Novel Therapy of Obesity: Implications for Cardiovascular Disease Douglas Losordo, MD - Adult Stem Cells: Fact or Fiction H. Kirk Hammond, MD - Adenylyl Cyclase Gene Transfer for Heart Failure Scientific Symposium 402 Hemopoietic: Advances in Stem Cell Self Renewal Room: 260/264 Co-Chairs: David W. Emery, PhD Karen E. Pollok, PhD Speakers: R. Keith Humphries, MD, PhD - Emerging Strategies for High Level Expansion of Hematopoietic Stem Cells C. Anthony Blau, MD - Pharmacologically Regulated Cell Therapy Akihiro Kume, MD, PhD - On-demand Expansion of Genetically Corrected Blood Cells Scientific Symposium 403 Oligonucleotide Based Therapies: Emerging Applications of Oligonucleotide Therapeutics Room: 240 Complex Chair: Dieter Gruenert, PhD Speakers: Bruce Sullenger, PhD - Aptamer-Antidote Pairs as a Novel Approach to Safer Drug Design Mark A. Kay, MD, PhD - RNAi Based Approaches for Treatment of Human Hepatitis Viral Infection Peter Glazer, MD, PhD - Targeted Gene Correction via Triplex Formation Andrew Ellington, PhD - Aptamer Inhibition of HIV Scientific Symposium 404 Viral: Vector Cell Interactions Room: 263/267 Chair: Kenneth Cornetta, PhD Speakers: Glen R. Nemerow, PhD - Adenovirus Cell Entry Mechanisms Arun Srivastava, PhD - AAV-mediated Transgene Expression: Second-strand Synthesis Versus Strand-annealing Nicholas Muzyczka, PhD - Targeting AAV Vectors BREAK – 10:00 AM - 10:15 AM SIMULTANEOUS ORAL ABSTRACT SESSIONS – 10:15 AM - 12:15 PM Oral Abstract Session 410 DNA Viruses: Vaccines, HSV, Baculovirus and SV40 Room: 240 Complex Co-Chairs: David Krisky, MD, PhD Yoshinaga Saeki, MD, PhD (Abstracts #755 - #762) Oral Abstract Session 411 Naked DNA Gene Transfer: Optimizing Expression/ Animal Models Room: 260/264 Co-Chairs: Ronald K. Scheule, PhD Carol H. Miao, PhD (Abstracts #763 - #770) Oral Abstract Session 412 Lipid Mediated Gene Transfer: Non Viral Delivery Systems Room: 263/267 Co-Chairs: Ralph W. Paul, PhD James E. Hagstrom, PhD (Abstracts #771 - #778)
Page 1 and 2: AMERICAN SOCIETY OF GENE THERAPY 8t
Page 3 and 4: 2 8th Annual Meeting • June 1 - 5
Page 11 and 12: 10 8th Annual Meeting • June 1 -
Page 37: 36 8th Annual Meeting • June 1 -
Page 89 and 90:
88 8th Annual Meeting • June 1 -
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
156 NOTES 8th Annual Meeting • Ju
show all

FINAL PROGR AM - American Society of Gene & Cell Therapy

Create successful ePaper yourself

Delete template?

Save as template?